Dipeptidyl Peptidase 3, a Biomarker in Cardiogenic Shock and Hopefully Much More
Key result
Dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics, supporting its role as a myocardial depressant factor in cardiogenic shock.
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
This is an editorial discussing the role of dipeptidyl peptidase 3 as a biomarker and potential therapeutic target in cardiogenic shock.
Key Points
Key points are not available for this paper at this time.
Cite This Study
Magliocca et al. (2019) studied this question. Dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics, supporting its role as a myocardial depressant factor in cardiogenic shock.